| abstract |
The present invention provides compositions and methods for delivering carbon monoxide (CO) to subjects suffering from inflammatory, cardiovascular, sickle cell and other diseases. The compositions are liquids, including Newtonian liquids and non-Newtonian liquids, such as pastes, gels, foams, emulsions, and other non-gaseous compositions, wherein the CO is in a therapeutically or prophylactically effective amount to provide the patient when administered to the patient. The amount of CO was dissolved. The composition can be provided in many forms, including in bottles or cans. |